The verdict
Our read at a glance.
Whether carbetocin's benefit is understood as a single-dose uterotonic to prevent postpartum bleeding, comparable to oxytocin but longer-acting and heat-stable, rather than interchangeable with oxytocin or useful beyond childbirth.
- The signal
- A large World Health Organization trial found heat-stable carbetocin worked about as well as oxytocin at preventing postpartum hemorrhage after vaginal birth, with the practical advantage of not needing refrigeration.
- The unknown
- Its best role across different delivery settings and cost constraints, and how it compares with oxytocin and other uterotonics in higher-risk situations.
- Our read
- A practical, well-evidenced tool against bleeding after childbirth. Carbetocin matches oxytocin for preventing postpartum hemorrhage in the settings studied and adds the real-world advantage of heat stability, though it is not FDA-approved in the US and is a distinct, longer-acting drug from oxytocin.
The mechanism
How it works.
After a baby is delivered, the uterus has to clamp down to squeeze shut the blood vessels where the placenta was attached; if it stays floppy, heavy bleeding follows. Oxytocin is the natural hormone that drives those contractions, but it breaks down quickly and usually needs a drip. Carbetocin is a modified, sturdier version of oxytocin that binds the same oxytocin receptors on the uterus but lasts much longer, so a single dose keeps the uterus contracted. A heat-stable formulation stays effective without refrigeration, which is the key practical advance for places where keeping oxytocin cold is difficult.
Safety & regulatory boundary
The consequential part.
Carbetocin's side effects are similar to oxytocin, including low blood pressure, flushing, nausea, and headache, and it is given once around the time of delivery. It is not FDA-approved in the United States; it is approved in many other countries and the heat-stable form is WHO-recommended. Carbetocin and oxytocin are different drugs, and carbetocin is longer-acting, so they are not interchangeable dose-for-dose.
What's next
What we're watching.
Wider rollout and real-world results of heat-stable carbetocin in low-resource settings, cost-effectiveness, and comparisons with oxytocin and combination uterotonics.
Context
Why this is discussed.
Bleeding after childbirth is a leading cause of maternal death worldwide. Carbetocin is a longer-acting cousin of oxytocin that works with a single dose, and its heat-stable form does not need refrigeration, which matters where reliable cold storage is hard.
The evidence base
19 cited references.
Registered trials8
ClinicalTrials.gov · PHASE4 · NOT_YET_RECRUITING · 2026-08
ClinicalTrials.gov · PHASE4 · RECRUITING · 2026-05-05
ClinicalTrials.gov · NA · RECRUITING · 2024-04-04
ClinicalTrials.gov · NA · RECRUITING · 2025-12-01
ClinicalTrials.gov · NA · RECRUITING · 2025-01-14
ClinicalTrials.gov · NA · COMPLETED · 2024-10-01
ClinicalTrials.gov · PHASE4 · COMPLETED · 2019-04-02
ClinicalTrials.gov · NA · RECRUITING · 2026-01-18
Indexed literature (PubMed)11
Miller HE et al. · Curr Opin Obstet Gynecol · 2022
Jones AJ et al. · Am J Obstet Gynecol MFM · 2023
Hersh AR et al. · Am J Obstet Gynecol · 2024
Amaral S et al. · Lancet Glob Health · 2025
Onwochei DN et al. · Best Pract Res Clin Anaesthesiol · 2024
Heesen M et al. · Anaesthesia · 2019
Roof E et al. · J Clin Endocrinol Metab · 2023
Gallos ID et al. · Cochrane Database Syst Rev · 2025
Onwochei DN et al. · Can J Anaesth · 2020
Maged AM et al. · J Obstet Gynaecol Res · 2025
Albazee E et al. · Cureus · 2022
Keep reading